At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Kaohsiung Medical University Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital·observational·Posted Mar 9, 2012·Updated Oct 8, 2015
In Brief
An observational study for Hepatocellular Carcinoma. Completed, enrolled 105 participants across 1 site.
Detailed Summary
The purposes of this prospective study were to evaluate the successful rate of primary culture of hepatocellular carcinoma cells and cancer-associated fibroblasts from the residual specimens in routine fine-needle aspiration of hepatic tumor and the potential application of this method as an additional tool for personalized treatment of hepatocellular carcinoma patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinoma
CountriesTaiwan
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedMar 2012
Primary CompletionJan 2013
Study CompletionJul 2013
TodayJul 2026
First PostedMar 9, 2012
Enrollment StartApr 1, 2010
Primary CompletionJan 1, 2013
Study CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.3 years ago